Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antibacterial
    (21)
  • Antibiotic
    (11)
  • Antifungal
    (3)
  • Anti-infection
    (1)
  • Antifection
    (1)
  • Autophagy
    (1)
  • Cell wall
    (1)
  • Endogenous Metabolite
    (1)
  • ROS
    (1)
  • Others
    (7)
Filter
Search Result
Results for "

enterococci

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    22
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Natural Products
    10
    TargetMol | Natural_Products
  • Disease Modeling
    1
    TargetMol | Disease_Modeling_Products
Vulpinic Acid
Vulpic acid, Pulvinic acid methyl ester
T3982521-52-8
Vulpinic Acid (Pulvinic acid methyl ester) is a lichen metabolite with anti-inflammatory, antibacteria, properties, plant growth inhibitor.
  • $30
In Stock
Size
QTY
Vancomycin hydrochloride
Vancomycin HCl
T08321404-93-9
Vancomycin hydrochloride (Vancomycin HCl) is a glycopeptide antibiotic that targets Peptidoglycan in bacterial cell wall synthesis. Vancomycin hydrochloride is mainly used for the treatment of severe Gram-positive bacterial infections.
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
Epicorazine B
TN1000369176-72-3
Epicorazine B exhibits activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), with a minimum inhibitory concentration (MIC) of 12.5-25 μg/mL. It is also effective against Candida albicans, with an MIC of 25 μg/mL.
  • Inquiry Price
10-14 weeks
Size
QTY
Chloropolysporin C
TN10100105650-12-2
Chloropolysporin C exhibits significant activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and enterococci.
  • Inquiry Price
Inquiry
Size
QTY
Diperamycin
TN10194220766-06-3
Diperamycin demonstrates activity against Gram-positive bacteria, including Enterococci and MRSA, with MIC ranging from 0.10 to 0.20 μg/mL. It also strongly inhibits the activity of cell lines L1210, P388, LS-180, KB, HeLaS3, Meth A, and B16-BL6, with IC50 values between 0.009 and 0.098 μg/mL.
  • Inquiry Price
Inquiry
Size
QTY
Citreamicin alpha
LL-E19085α
TN11142122535-63-1
Citreamicin alpha (LL-E 19085-alpha) is an antibiotic that has been evaluated for its in vitro antibacterial activity against 429 clinical isolates of Gram-positive cocci using the agar dilution method. This study included 313 strains of staphylococci and 116 strains of streptococci. Its in vitro efficacy was compared with ampicillin, amoxicillin, cephalothin, erythromycin, and vancomycin. For staphylococci, Citreamicin alpha demonstrated MIC values ranging from 0.12 to 4.0 μg/ml, and for Streptococcus pyogenes, the MIC values ranged from 0.03 to 0.12 μg/ml. Conversely, enterococci presented relative resistance, requiring 2.0 μg/ml to inhibit 64% of 62 tested strains. The antibiotic's in vitro efficacy significantly surpassed that of ampicillin, amoxicillin, cephalothin, and erythromycin, while it was comparable to or slightly less effective than vancomycin.
  • Inquiry Price
10-14 weeks
Size
QTY
8-Epidiosbulbin E acetate
TN134291095-48-6
8-Epidiosbulbin E acetate is a abundant furan compound found in Dioscorea bulbifera L., exhibiting broad-spectrum plasmid elimination activity against multidrug-resistant bacteria, and can be used to induce liver injury models in mice.
  • $52
In Stock
Size
QTY
Glyasperin C
TN4148142474-53-1
Glyasperin C acts as a partial estrogen antagonist, it shows tyrosinase inhibitory activity (IC (50) = 0.13 +/- 0.01 microg/mL), it could be a promising candidate in the design of skin-whitening agents. Glyasperin C shows potent anti-vancomycin-resistant
  • $586
Inquiry
Size
QTY
Chloropolysporin B
TN9954105650-11-1
Chloropolysporin B exhibits potent activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and enterococci.
  • Inquiry Price
Inquiry
Size
QTY
Epicorazine A
TN998962256-05-7
Epicorazine A exhibits activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), with a minimum inhibitory concentration (MIC) of 12.5-25 μg/mL. It is also effective against Candida albicans, showing an MIC of 25 μg/mL.
  • Inquiry Price
10-14 weeks
Size
QTY